Effect of Haloperidol and Risperidone on Serum Melatonin and GAP-43 in Patients with Schizophrenia: A Prospective Cohort Study

키워드

참고문헌 (47)

1. Lieberman JA, "Neurochemistry and neuroendocrinology of schizophrenia : a selective review", Schizophr Bull, 19, pp.371~429 (1993)
2. Tandon R, "Schizophrenia, "just the facts" : what we know in 2008 part 1 : overview", Schizophr Res, 100, pp.4~19 (2008)
3. Lieberman JA, "Hippocampal dysfunction in the pathophysiology of schizophrenia : a selective review and hypothesis for early detection and intervention", Mol Psychiatry, 23, pp.1764~1772 (2018)
4. Yates NJ, "Schizophrenia : the role of sleep and circadian rhythms in regulating dopamine and psychosis", Rev Neurosci, 27, pp.669~687 (2016)
5. Tam SK, "Sleep and circadian rhythm disruption and recognition memory in schizophrenia", Methods Enzymol, 552, pp.325~349 (2015)
6. Cosgrave J, "Sleep, circadian rhythms, and schizophrenia : where we are and where we need to go", Curr Opin Psychiatry, 31, pp.176~182 (2018)
7. Benson KL, "Sleep in schizophrenia : pathology and treatment", Sleep Med Clin, 10, pp.49~55 (2015)
8. Kaskie RE, "Schizophrenia and sleep disorders : links, risks, and management challenges", Nat Sci Sleep, 9, pp.227~239 (2017)
9. Kamath J, "Sleep disturbances in schizophrenia", Psychiatr Clin North Am, 38, pp.777~792 (2015)
10. Klingaman EA, "Sleep disorders among people with schizophrenia : emerging research", Curr Psychiatry Rep, 17, pp.79~ (2015)
11. Rébecca Robillard, "Are Cardiometabolic and Endocrine Abnormalities Linked to Sleep Difficulties in Schizophrenia? A Hypothesis Driven Review", Clinical Psychopharmacology and Neuroscience, 10(1), pp.1~12 (2012), 대한정신약물학회[DOI]
12. Bromundt V, "Sleep-wake cycles and cognitive functioning in schizophrenia", Br J Psychiatry, 198, pp.269~276 (2011)
13. Wulff K, "Sleep and circadian rhythm disruption in schizophrenia", Br J Psychiatry, 200, pp.308~316 (2012)
14. Morera-Fumero AL, "Role of melatonin in schizophrenia", Int J Mol Sci, 14, pp.9037~9050 (2013)
15. Anderson G, "Melatonin : an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects", Metab Brain Dis, 27, pp.113~119 (2012)
16. Ferrier IN, "Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight", Clin Endocrinol(Oxf), 17, pp.181~187 (1982)
17. Fanget F, "Nocturnal plasma melatonin levels in schizophrenic patients", Biol Psychiatry, 25, pp.499~501 (1989)
18. Robinson S, "Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients", Acta Psychiatr Scand, 84, pp.221~224 (1991)
19. Monteleone P, "Decreased nocturnal secretion of melatonin in drug-free schizophrenics : no change after subchronic treatment with antipsychotics", Neuropsychobiology, 36, pp.159~163 (1997)
20. Sandyk R, "Pineal melatonin in schizophrenia : a review and hypothesis", Schizophr Bull, 16, pp.653~662 (1990)
21. Owen F, "Hydroxy-indole-omethyltransferase activity in human pineals: a comparison of controls and schizophrenics", Clin Endocrinol(Oxf), 19, pp.313~317 (1983)
22. Chambers JS, "Growth-associated protein 43(GAP-43)and synaptophysin alterations in the dentate gyrus of patients with schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 29, pp.283~290 (2005)
23. Benowitz LI, "GAP-43 : an intrinsic determinant of neuronal development and plasticity", Trends Neurosci, 20, pp.84~91 (1997)
24. Perrone-Bizzozero NI, "Levels of the growth-associated protein GAP-43are selectively increased in association cortices in schizophrenia", Proc Natl Acad Sci U S A, 93, pp.14182~14187 (1996)
25. Blennow K, "The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia", J Mol Neurosci, 13, pp.101~109 (1999)
26. Sower AC, "Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method", Mol Chem Neuropathol, 24, pp.1~11 (1995)
27. Weickert CS, "Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia", Cereb Cortex, 11, pp.136~147 (2001)
28. Webster MJ, "Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia", Schizophr Res, 49, pp.89~98 (2001)
29. Hakak Y, "Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia", Proc Natl Acad Sci U S A, 98, pp.4746~4751 (2001)
30. Eastwood SL, "Hippocampal and cortical growthassociated protein-43 messenger RNA in schizophrenia", Neuroscience, 86, pp.437~448 (1998)
31. Juan WS, "Melatonin improves neuroplasticity by upregulating the growth-associated protein-43(GAP-43)and NMDAR postsynaptic density-95(PSD-95)proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal cerebral ischemia even during a long-term recovery period", J Pineal Res, 56, pp.213~223 (2014)
32. Shen YC, "Genetic and functional analysis of the gene encoding GAP-43in schizophrenia", Schizophr Res, 134, pp.239~245 (2012)
33. Mann K, "Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine", Psychoneuroendocrinology, 31, pp.256~264 (2006)
34. Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
35. Buysse DJ, "The Pittsburgh Sleep Quality Index : a new instrument for psychiatric practice and research", Psychiatry Res, 28, pp.193~213 (1989)
36. Mills MH, "Melatonin determination in human urine by high-performance liquid chromatography with fluorescence detection", J Chromatogr, 377, pp.350~355 (1986)
37. Stępnicki P, "Current concepts and treatments of schizophrenia", Molecules, 23, pp.2087~ (2018)
38. Monti JM, "Sleep and circadian rhythm dysregulation in schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 43, pp.209~216 (2013)
39. Zhdanova IV, "Endogenous melatonin levels and the fate of exogenous melatonin : age effects", J Gerontol A Biol Sci Med Sci, 53, pp.B293~ (1998)
40. Eastwood SL, "Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes", Mol Psychiatry, 2, pp.322~329 (1997)
41. Yamashita H, "Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia : comparison of middle-aged and older adults", Am J Geriatr Psychiatry, 13, pp.377~384 (2005)
42. Hajak G, "Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects", Eur Neuropsychopharmacol, 6, pp.149~153 (1996)
43. Kabuto M, "Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans", Endocrinol Jpn, 33, pp.405~414 (1986)
44. Monteleone P, "Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans", J Pineal Res, 6, pp.253~258 (1989)
45. McIntyre IM, "Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans", Biol Psychiatry, 24, pp.108~112 (1988)
46. Norman TR, "The effect of single oral doses of zopiclone on nocturnal melatonin secretion in healthy male volunteers", Prog Neuropsychopharmacol Biol Psychiatry, 25, pp.825~833 (2001)
47. Mishra A, "Effect of add-on ramelteon therapy on sleep and circadian rhythm disruption in patients with schizophrenia : a randomized controlled trial", Eur Neuropsychopharmacol, 31, pp.109~118 (2020)

관련 논문AI추천